Chick-fil-A Dawg Bowl 2023, hosted by former Bulldogs football coach Mark Richt, has raised more than $758,000 to support research on Parkinson’s disease at the University of Georgia (UGA). Launched by a $500,000 donation from the Richt Family Foundation, all the proceeds will go to UGA’s Isakson…
Gender norms and stereotypes substantially can impact the well-being of men and women living with Parkinson’s disease, highlighting a need for more gender-sensitive care, according to a small study into patients’ views. People with Parkinson’s in the Netherlands indicated that their behaviors and experiences were affected both by masculine…
Parkinson’s UK is highlighting the efforts of those working to improve the representation of people with African and Caribbean lineage in Parkinson’s disease research as part of Black History Month, observed every October in the United Kingdom. The nonprofit organization is also calling attention to a free online…
Treatment with cianidanol, a plant molecule that can activate a specific estrogen receptor in the brain, showed neuroprotective potential in cell and animal models of Parkinson’s disease, a study reports. “The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective…
A new set of guidelines, developed by a team of scientists in China, outline ways healthcare professionals can help people with Parkinson’s disease to deal with constipation — and the focus is on  emotional support to help patients, and emphasizing the importance of open dialogue. The study, “Breaking…
It may be possible to spot telltale signs of Parkinson’s disease on positron emission tomography (PET) scans as early as 20 to 30 years before symptoms become evident and a definite clinical diagnosis can be made, a study suggests. PET scans that track a protein called vesicular…
The use of over-the-counter pain medicines like ibuprofen and aspirin do not appear to influence the clinical progression of Parkinson’s disease, a recent study reveals. The study, “Non-steroidal anti-inflammatory drug use and markers of Parkinson’s disease progression: A retrospective cohort study,” was published in the Journal…
Botulinum toxin was found to be relatively safe and effective for treating excessive drooling in people with Parkinson’s disease, according to a recent systematic review and meta-analysis of previous clinical trials. While side effects usually were mild, the researchers believe larger and longer studies are needed to establish the…
Cure Parkinson’s is funding preclinical research that intends to provide the evidence needed to determine whether three existing compounds are ready to move forward into clinical trials in people with Parkinson’s disease, the U.K. charity announced. The funding comes as part of the recently launched Pipeline Research…
A once-daily 200 mg dose of Inhibikase Therapeutics’ risvodetinib — an oral medication previously called IkT-148009, now undergoing Phase 2 clinical testing — is safe, and can improve motor function and ease activities of daily living in people with previously untreated Parkinson’s disease. That’s according to now…
Get regular updates to your inbox.
